Agentix (AGTX) Income from Non-Controlling Interests (2016 - 2022)
Agentix's (AGTX) quarterly Income from Non-Controlling Interests came in at -$355863.0 in Q4 2022, down 5651.68% on a QoQ basis from $6410.0 in Q3 2016.
Agentix (AGTX) Income from Non-Controlling Interests (2016 - 2022) Analysis & Trends
Agentix (AGTX) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$355863.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 63.60 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -355,863.00 |
| Aug 31, 2016 | 6,410.00 |
| May 31, 2016 | -3,205.00 |